APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027

Abstract
The Asia Pacific spatial genomics and transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are growing number of consumables for various spatial genomics and transcriptomics applications, introduction of novel products, and increasing adoption of spatial genomics & transcriptomics in drug discovery & development. However, the high capital investments associated with spatial genomics and transcriptomics are expected to restrain market growth to a certain extent.

The Asia Pacific spatial genomics and transcriptomics market has been segmented based on product, technique, application, end user, and country.

“By application, the translational research accounted for the largest share of the Asia Pacific spatial genomics & transcriptomics market”

Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.

“By technique, the spatial transcriptomics accounted for the largest share in the Asia Pacific spatial genomics & transcriptomics market”

Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for a larger share of the Asia Pacific spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.
 
“China: the largest share of the spatial genomics & transcriptomics market”

China accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding by the government and biopharma companies for the development of new regenerative medicine are the major factors driving the market growth.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 60% and Demand Side 40%
•By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
•By Country: Japan- 22%, China- 47%, India- 11%, Rest of APAC- 20%

Prominent Players
•NanoString Technologies, Inc. (US)
•10X Genomics (US)
•Illumina (US)
•Bio-Rad Laboratories (US)
•Bio-Techne Corporation (US)
•Standard BioTools Inc. (US)
•Genomic Vision SA (France)
•Akoya Biosciences, Inc. (US)
•S2 Genomics (US)
•Cantata Bio (US)
•Vizgen Group (US)
•BGI Group (China)
•Miltenyi Biotec (Germany)
•Bruker (US)
•Perkinelmer Inc. (US)
•Novogene Co., Ltd. (China)

Research Coverage:
This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and country. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

Content
Table of Contents

1INTRODUCTION14
1.1STUDY OBJECTIVES14
1.2MARKET DEFINITION14
1.2.1INCLUSIONS AND EXCLUSIONS14
1.3STUDY SCOPE15
1.4YEARS CONSIDERED15
1.5CURRENCY CONSIDERED16
1.6LIMITATIONS16
1.7STAKEHOLDERS16
2RESEARCH METHODOLOGY17
2.1RESEARCH DATA17
FIGURE 1RESEARCH DESIGN17
2.1.1SECONDARY DATA18
2.1.2PRIMARY DATA19
FIGURE 2BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET19
2.2MARKET ESTIMATION METHODOLOGY20
FIGURE 3MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)20
FIGURE 4ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)20
FIGURE 5ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027)21
FIGURE 6ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES21
2.3MARKET DATA ESTIMATION AND TRIANGULATION22
FIGURE 7DATA TRIANGULATION METHODOLOGY22
2.4INDUSTRY INSIGHTS23
2.5RESEARCH ASSUMPTIONS23
3EXECUTIVE SUMMARY24
FIGURE 8ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)24
FIGURE 9ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)25
FIGURE 10ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)25
FIGURE 11ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)26
FIGURE 12ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 202127
4PREMIUM INSIGHTS28
4.1ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW28
FIGURE 13REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH28
4.2JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021)29
FIGURE 14CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN29
4.3CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021)29
FIGURE 15TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA29
5MARKET OVERVIEW30
5.1INTRODUCTION30
5.2MARKET DYNAMICS30
FIGURE 16ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES30
TABLE 1ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS31
5.2.1DRIVERS31
5.2.1.1Reduced cost of next-generation sequencing31
5.2.1.2Increasing adoption of spatial genomics and transcriptomics in drug discovery and development32
5.2.2RESTRAINTS32
5.2.2.1High capital investments32
5.2.3OPPORTUNITIES32
5.2.3.1Increasing demand for single-cell analysis32
5.2.4CHALLENGES33
5.2.4.1Analytical limitations associated with spatial techniques33
5.3TECHNOLOGY ANALYSIS33
TABLE 2FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS34
5.4VALUE CHAIN ANALYSIS35
TABLE 3INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC35
FIGURE 17ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS36
5.5ECOSYSTEM ANALYSIS36
FIGURE 18SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS37
5.6PORTER’S FIVE FORCES ANALYSIS37
TABLE 4ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS37
5.6.1THREAT OF NEW ENTRANTS37
5.6.2THREAT OF SUBSTITUTES37
5.6.3BARGAINING POWER OF BUYERS38
5.6.4BARGAINING POWER OF SUPPLIERS38
5.6.5INTENSITY OF COMPETITIVE RIVALRY38
5.7REGULATORY ANALYSIS38
5.7.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS38
TABLE 5ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS38
5.8PRICING ANALYSIS39
TABLE 6PRODUCT PRICING: KEY MARKET PLAYERS39
5.8.1AVERAGE SELLING PRICE TREND39
5.9KEY CONFERENCES AND EVENTS (2020–2023)39
TABLE 7SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023)39
5.10KEY STAKEHOLDERS AND BUYING CRITERIA40
5.10.1KEY STAKEHOLDERS IN BUYING PROCESS40
FIGURE 19INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS40
5.10.2BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION40
FIGURE 20KEY BUYING CRITERIA FOR END USERS40
6ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY PRODUCT41
6.1INTRODUCTION42
TABLE 8ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)42
6.2CONSUMABLES42
6.2.1GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH42
TABLE 9ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)43
6.3INSTRUMENTS43
6.3.1INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET43
TABLE 10ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)44
6.4SOFTWARE44
6.4.1RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE44
TABLE 11ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)45
 
7SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE46
7.1INTRODUCTION47
TABLE 12ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)47
7.2SPATIAL TRANSCRIPTOMICS47
TABLE 13ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)47
TABLE 14ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)48
7.2.1IMMUNOHISTOCHEMISTRY48
7.2.1.1Emergence of mIHC/IF to propel growth48
TABLE 15ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)49
7.2.2IN SITU HYBRIDIZATION49
7.2.2.1High adoption of MERFISH to drive growth49
TABLE 16ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)50
7.2.3SPATIAL TRANSCRIPTOMIC SEQUENCING50
TABLE 17ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)50
7.2.3.1Microdissection-based sequencing51
7.2.3.1.1Increasing use of microdissection-based sequencing to contribute to market growth51
TABLE 18ASIA PACIFIC: MICRODISSECTION-BASED SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)51
7.2.3.2In situ sequencing52
7.2.3.2.1Increased adoption of in situ sequencing likely to boost market growth52
TABLE 19ASIA PACIFIC: IN SITU SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)52
7.2.3.3Other sequencing technologies53
TABLE 20ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)53
7.2.4MICROSCOPY-BASED RNA IMAGING53
7.2.4.1Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth53
TABLE 21ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)54
7.2.5OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES54
TABLE 22ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)54
7.3SPATIAL GENOMICS ANALYSIS55
TABLE 23ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)55
TABLE 24ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)55
7.3.1FLUORESCENCE IN SITU HYBRIDIZATION56
7.3.1.1Emerging potential of spatial genomics analysis in cancer diagnostics to support growth56
TABLE 25ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)56
7.3.2SPATIAL GENOMIC SEQUENCING56
7.3.2.1Rising adoption of massively parallel sequencing to drive growth56
TABLE 26ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)57
7.3.3OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES57
TABLE 27ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)57
8ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY APPLICATION58
8.1INTRODUCTION59
TABLE 28ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)59
8.2TRANSLATIONAL RESEARCH59
8.2.1DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH59
TABLE 29ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)60
8.3DRUG DISCOVERY AND DEVELOPMENT60
8.3.1RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH60
TABLE 30ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)61
9ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY END USER62
9.1INTRODUCTION63
TABLE 31ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)63
9.2ACADEMIC AND RESEARCH INSTITUTES63
9.2.1INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH63
TABLE 32ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)64
9.3CONTRACT RESEARCH ORGANIZATIONS64
9.3.1INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH64
TABLE 33ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)65
9.4PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES65
9.4.1GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS65
TABLE 34ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)66
10ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY COUNTRY67
10.1INTRODUCTION68
TABLE 35ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)68
10.2CHINA68
10.2.1INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH68
TABLE 36CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)69
TABLE 37CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)69
TABLE 38CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)69
TABLE 39CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)70
TABLE 40CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)70
TABLE 41CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)70
10.3JAPAN71
10.3.1RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS71
TABLE 42JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)71
TABLE 43JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)71
TABLE 44JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)72
TABLE 45JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)72
TABLE 46JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)72
TABLE 47JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)73
10.4INDIA73
10.4.1COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH73
TABLE 48INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)73
TABLE 49INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)74
TABLE 50INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)74
TABLE 51INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)74
TABLE 52INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)75
TABLE 53INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)75
10.4.2SINGAPORE75
10.4.2.1Active partnerships with key players to boost market growth75
TABLE 54SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)76
TABLE 55SINGAPORE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)76
TABLE 56SINGAPORE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)77
TABLE 57SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)77
TABLE 58SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)77
TABLE 59SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)78
10.4.3SOUTH KOREA78
10.4.3.1Government initiatives and strong R&D expenditure to propel demand for spatial solutions78
TABLE 60SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)78
TABLE 61SOUTH KOREA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)79
TABLE 62SOUTH KOREA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)79
TABLE 63SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)80
TABLE 64SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)80
TABLE 65SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)80
10.4.4AUSTRALIA81
10.4.4.1Increasing adoption of spatial solutions by research institutions to propel growth81
TABLE 66AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)81
TABLE 67AUSTRALIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)82
TABLE 68AUSTRALIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)82
TABLE 69AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)83
TABLE 70AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)83
TABLE 71AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)83
10.4.5REST OF ASIA PACIFIC84
TABLE 72REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)84
TABLE 73REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)84
TABLE 74REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)85
TABLE 75REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)85
TABLE 76REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)85
TABLE 77REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)86
11COMPETITIVE LANDSCAPE87
11.1INTRODUCTION87
11.2RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS87
FIGURE 21SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS88
11.3REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)89
11.4MARKET SHARE ANALYSIS (2021)89
11.5COMPANY EVALUATION MATRIX91
11.5.1STARS91
11.5.2EMERGING LEADERS91
11.5.3PERVASIVE PLAYERS91
11.5.4PARTICIPANTS91
FIGURE 24SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)92
11.6COMPETITIVE SCENARIO AND TRENDS93
11.6.1DEALS93
TABLE 78ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS93
11.6.1.1Product launches94
TABLE 79ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES94
11.6.1.2Other developments94
TABLE 80ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS94
 
12COMPANY PROFILES95
12.1KEY PLAYERS95
(Business Overview, Products, Recent Developments, MnM View)*
12.1.1NANOSTRING95
TABLE 81NANOSTRING: BUSINESS OVERVIEW95
FIGURE 25NANOSTRING: COMPANY SNAPSHOT (2021)96
12.1.210X GENOMICS101
TABLE 8210X GENOMICS: BUSINESS OVERVIEW101
FIGURE 2610X GENOMICS: COMPANY SNAPSHOT (2021)102
12.1.3ILLUMINA105
TABLE 83ILLUMINA: BUSINESS OVERVIEW105
FIGURE 27ILLUMINA: COMPANY SNAPSHOT (2021)106
12.1.4BIO-RAD LABORATORIES, INC.111
TABLE 84BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW111
FIGURE 28BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)112
12.1.5BIO-TECHNE114
TABLE 85BIO-TECHNE: BUSINESS OVERVIEW114
FIGURE 29BIO-TECHNE: COMPANY SNAPSHOT (2021)115
12.1.6STANDARD BIOTOOLS120
TABLE 86STANDARD BIOTOOLS: BUSINESS OVERVIEW120
FIGURE 30STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)121
12.1.7AKOYA BIOSCIENCES127
TABLE 87AKOYA BIOSCIENCES: BUSINESS OVERVIEW127
FIGURE 31AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)127
12.1.8S2 GENOMICS131
TABLE 88S2 GENOMICS: BUSINESS OVERVIEW131
12.1.9CANTATA BIO132
TABLE 89CANTATA BIO: BUSINESS OVERVIEW132
12.1.10VIZGEN CORP.133
TABLE 90VIZGEN: BUSINESS OVERVIEW133
*Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies.
12.2OTHER PLAYERS134
12.2.1BGI GROUP134
12.2.2MILTENYI BIOTEC134
12.2.3BRUKER135
12.2.4PERKINELMER INC.135
12.2.5NOVOGENE CO., LTD.136
13APPENDIX137
13.1DISCUSSION GUIDE137
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL140
13.3CUSTOMIZATION OPTIONS142
13.4RELATED REPORTS142
13.5AUTHOR DETAILS143